Evidence map›Paper›PMID 31040685›Full record

ArticleNeuropsychiatric disease and treatment2019

Fluvoxamine treatment response prediction in obsessive-compulsive disorder: association rule mining approach.

Hesam Hasanpour, Ramak Ghavamizadeh Meibodi, Keivan Navi, Jamal Shams, Sareh Asadi, Abolhassan Ahmadiani

Open access · goldAbstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hesam HasanpourFaculty of Computer Science and Engineering, Shahid Beheshti University, Tehran, Iran.
Ramak Ghavamizadeh MeibodiFaculty of Computer Science and Engineering, Shahid Beheshti University, Tehran, Iran.
Keivan NaviFaculty of Computer Science and Engineering, Shahid Beheshti University, Tehran, Iran.
Jamal ShamsBehavioral Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sareh AsadiNeurobiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, s.asadi@sbmu.ac.ir.
Abolhassan AhmadianiNeuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, aahmadiani@yahoo.com.
Shahid Beheshti University · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObsessive-compulsive disorder (OCD) is a debilitating psychiatric disorder characterized by intrusive thoughts or repetitive behaviors. Clinicians use serotonin reuptake inhibitors (SRIs) for OCD treatment, but 40%-60% of the patients do not respond to them adequately. Here, we described an association rule mining approach for treatment response prediction using an Iranian OCD data set. PATIENTS AND

methodsThree hundred and thirty OCD patients fulfilling

resultsResults showed that low obsession and compulsion severities, family history of mental illness, illness duration less than 5 years, being married, and female were the most associated variables with responsiveness to fluvoxamine pharmacotherapy. Meanwhile, if an OCD patient reported a family history of mental illness and his/her illness duration was less than 5 years, he/she responded to 12-week fluvoxamine pharmacotherapy with the probability of 91%. We also found useful and applicable rules for resistant and refractory patients.

conclusionThis is the first study where association rule mining approach was used to extract predicting rules for treatment response in OCD. Application of this method in personalized medicine may help clinicians in taking the right therapeutic decision.

Indexed as

apriori algorithmdata miningfamily historyrefractory patients

Identifiers

PMID31040685
PMCPMC6462161
OpenAlexW2937550919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.